Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Qatar University Plans BSL-3 Select Agent Laboratory
Qatar University has selected WorkingBuildings of Atlanta to design, build, and provide operational support for the new BSL-3 Select Agent Laboratory in Doha, Qatar. Located at the New Research Complex, the facility will support the study of emerging infectious diseases and other biological threats. The laboratory will enable rapid response to regional public health issues as well as accommodating investigations involving biological or chemical terrorism.
Boehringer Ingelheim Vetmedica Expands Iowa Research Facilities
Boehringer Ingelheim Vetmedica will invest $110 million over the next four years to expand its operations in Iowa, enabling the company to increase production capacity and optimize manufacturing processes. In Ames, a 52,088-sf animal health research facility will be built in the Iowa State Research Park. On the Fort Dodge campus, a new Veterinary Research Center and a high-speed fill and freeze-drying suite will be constructed and existing infrastructure systems will be upgraded.
USDA Expands Southeast Poultry Research Lab
The U.S. Department of Agriculture is planning a 100,000-sf expansion and renovation of the Southeast Poultry Research Laboratory (SEPRL) in Athens. The $155 million project will support research on avian influenza and other infectious diseases at the 35-building complex. SEPRL was awarded $45 million in federal funding in December of 2014 to initiate the design and construction process.
Rajiv Gandhi National Centre for Biotechnology Plans BSL-4 Avian Flu Lab
Rajiv Gandhi National Centre for Biotechnology is planning to build a BSL-4 laboratory for avian influenza research in Thiruvananthapuram, India. The $9.7 million facility will be housed in the Microbial Containment Complex and will meet international safety standards. The project will support diagnostic testing for infectious diseases including H5N1, Ebola, Nipah, and Crimean Congo virus.
AstraZeneca Plans Cambridge R&D Headquarters
AstraZeneca will break ground in early 2015 on its $500 million Global R&D Centre and Corporate Headquarters in Cambridge in the United Kingdom. Providing sophisticated pharmaceutical discovery and development facilities, the project will include space for biologics research, high throughput screening, medicinal chemistry, pre-clinical research, and clinical development. The 11-acre campus will accommodate approximately 2,000 employees.